| 000 | 01785 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513140733.0 | ||
| 264 | 0 | _c19980413 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.1998.00532.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiacomelli, R | |
| 245 | 0 | 0 |
_aSerum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD). _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cMar 1998 |
||
| 300 |
_a532-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xblood |
| 650 | 0 | 4 |
_aCrohn Disease _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKi-1 Antigen _xblood |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPhytohemagglutinins _xpharmacology |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aTh2 Cells _ximmunology |
| 700 | 1 | _aPassacantando, A | |
| 700 | 1 | _aParzanese, I | |
| 700 | 1 | _aVernia, P | |
| 700 | 1 | _aKlidara, N | |
| 700 | 1 | _aCucinelli, F | |
| 700 | 1 | _aLattanzio, R | |
| 700 | 1 | _aSantori, E | |
| 700 | 1 | _aCipriani, P | |
| 700 | 1 | _aCaprilli, R | |
| 700 | 1 | _aTonietti, G | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 111 _gno. 3 _gp. 532-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.1998.00532.x _zAvailable from publisher's website |
| 999 |
_c9496518 _d9496518 |
||